Study Comparing Two Anesthetics for Arthroscopic Rotator Cuff Repair

NCT ID: NCT07093905

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to to compare the post-anesthetic recovery time to awake consciousness and hemodynamic and ventilatory capacities for discharge from the Post-Interventional Monitoring Room in patients admitted for shoulder rotator cuff arthroscopy (using local anesthesia versus general anesthesia + local anesthesia).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, comparative, randomized, open-label, multicenter study comparing two analgesic strategies used in outpatient, routine surgery.

The study population is composed of adult patients with complete or partial rotator cuff tears requiring reconstructive surgery under anesthesia at Hôpital Privé Clairval or Clinique Monticelli-Vélodrome.

Patients will be seen three times: at inclusion (during the preoperative consultation with the anesthetist), on the day of surgery (hospitalization), and at the follow-up visit (during the postoperative consultation with the surgeon). They will also be contacted by telephone on D1, D3 and D15 to optimize their follow-up. The duration of each patient's participation is approximately one month.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective, comparative, randomized, open-label, multicenter study comparing two analgesic strategies
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

open-label study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Locoregional anesthesia

patients will benefit from locoregional anesthesia alone by means of an interscalene block of the brachial plexus.

Group Type EXPERIMENTAL

arthroscopy of the shoulder rotator cuff

Intervention Type PROCEDURE

minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint

Locoregional anesthesia + general anesthesia

patients will benefit from general anesthesia as well as locoregional anesthesia via an interscalene block of the brachial plexus.

Group Type ACTIVE_COMPARATOR

arthroscopy of the shoulder rotator cuff

Intervention Type PROCEDURE

minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

arthroscopy of the shoulder rotator cuff

minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years;
* Patients with surgically repairable complete or partial rotator cuff tears;
* American Society of Anesthesiologists Class I to III;
* Patient able to understand study information;
* Patient willing to accept study evaluations and follow-up visits;
* Affiliation with a social insurance plan;
* Patient having been informed and having agreed to participate in the study by signing an informed consent form.

Exclusion Criteria

* Contraindication to general or locoregional anesthesia;
* Chronic opioid use;
* Patient unable to understand study information (linguistic, psychological, cognitive, etc.);
* Patient unable to answer a self-questionnaire;
* Patient participating in or being excluded from another interventional research study;
* Pregnant or breast-feeding women;
* Protected patient (under legal protection, guardianship or deprived of liberty by judicial or administrative decision).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Euraxi Pharma

INDUSTRY

Sponsor Role collaborator

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Privé Clairval

Marseille, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Matthieu CHIVOT, MD

Role: CONTACT

662347636 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matthieu CHIVOT

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00971-48

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Value of Capsular Repair for Latarjet
NCT05978362 RECRUITING NA